Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China.
Autor: | Ying, Zhitao1 (AUTHOR), Yang, Haiyan2 (AUTHOR), Guo, Ye3 (AUTHOR), Li, Wenyu4 (AUTHOR), Zou, Dehui5 (AUTHOR), Zhou, Daobin6 (AUTHOR), Wang, Zhao7 (AUTHOR), Zhang, Mingzhi8 (AUTHOR), Wu, Jianqiu9 (AUTHOR), Liu, Hui10 (AUTHOR), Zhang, Pian11 (AUTHOR), Yang, Su11 (AUTHOR), Zhou, Zisong11 (AUTHOR), Zheng, Hongxia11 (AUTHOR), Song, Yuqin1 (AUTHOR) songyuqin622@163.com, Zhu, Jun1 (AUTHOR) zhu-jun2017@outlook.com |
---|---|
Zdroj: | Cancer Medicine. Feb2021, Vol. 10 Issue 3, p999-1011. 13p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |